These effects of ribavirin were attributed to its ability to inhibit eukaryotic initiation factor 4E (eIF4E) and EZH2, both of which have been associated with MYC overexpression and group 3 medulloblastoma tumorigenesis [116]. This evidence concerns the gene EZH2 and medulloblastoma.